Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Neogen Corporation/ 8-K

Current Report · Items 2.02, 9.01 · 8-K

Neogen Corporation

NEOGNASDAQEQUITYCurrent

Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition On July 30, 2026, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 fourth quarter and full fiscal year ended May 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this report.…

Filed Jul 30, 2026Accepted Jul 30, 2026, 7:01 AM EDTCIK 711377Accession 0001193125-26-324860
View company →Permanent SEC source ↗
Share

Company context

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Current securities

NEOGNASDAQ · EQUITY · Current

Recent company filings

  1. ARS filingAug 21, 2026
  2. DEFA14A filingAug 21, 2026
  3. DEF 14A filingAug 21, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 7, 2026
  5. 10-K filingJul 30, 2026

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition On July 30, 2026, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 fourth quarter and full fiscal year ended May 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report, regardless of any general incorporation language in the filing.
Filed exhibits (1)
EX-99.1 (by filename) neog-ex99_1.htm

EX-99.1 2 neog-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results Delivered Strong Core Growth in Q4 FY26 with Food Safety Core Growth Highest Since FY23 • Fiscal fourth quarter 2026 revenue of $225.3 million representing growth of (0.1%) and Core Growth1 of 4.3%; Full fiscal year 2026 revenue of $870.4 million with growth of (2.7%) and Core Growth1 of 1.9% • Food Safety fourth quarter revenue growth of 3.1% and Core Growth1 of 5.8%; highest quarterly core growth rate since FY 2023 • Animal Safety fourth quarter revenue growth of (8.2%), Core Growth1 of 0.5%; revenue grew 7% sequentially due to resolution of the majority of supply challenges • Net loss of $11.3 million in the fourth quarter 2026 with EPS of $(0.05); Adjusted Net Income1 of $18.7 million and Adjusted EPS1 of $0.09 • Fourth quarter 2026 cash flow from operations of $30.2 million and free cash flow of $26.2 million • Fourth quarter 2026 Adjusted EBITDA1 of $45.4 million; with Adjusted EBITDA1 margin of 20.2% • Company on track to manufacture sellable Petrifilm® product and begin planned multi-quarter manufacturing transition in November 2026;…

Open exhibit ↗